[144] Life360, Inc. SEC Filing
Rhea-AI Filing Summary
Life360, Inc. Form 144: An officer or other person plans to sell 4,546 shares of Life360 common stock on 09/24/2025, with an aggregate market value reported as $461,509.92 and the sale venue listed as NASDAQ. The shares were acquired on 06/20/2024 through restricted stock vesting and were received as compensation. The filer also reported four prior sales over the past three months totaling 36,502 shares with reported gross proceeds of $2,482,157.96 across dates from 06/24/2025 to 09/05/2025. The filer certifies no undisclosed material adverse information in connection with this notice.
Positive
- None.
Negative
- Insider sales reported: Proposed sale of 4,546 shares (aggregate market value $461,509.92) and four prior sales totaling 36,502 shares in the past three months.
- Short time between vesting and sales: Shares were acquired via restricted stock vesting on 06/20/2024 and sales began within the following 12–15 months, as shown by the reported transactions.
- Increased supply: Reported sales add to public supply (transactions executed via Fidelity Brokerage Services LLC on NASDAQ).
Insights
TL;DR: Insider filing reports recent vested shares and continuing sales; material to trading liquidity but neutral on fundamentals.
The Form 144 shows a proposed sale of 4,546 shares (aggregate market value $461,509.92) to be executed on NASDAQ and indicates those shares were acquired via restricted stock vesting on 06/20/2024 as compensation. The filing also discloses four prior sales in the past three months totaling 36,502 shares with gross proceeds of $2,482,157.96. From a market perspective, these disclosures increase available float and document insider monetization. The form contains no information about company operations, financial results, or reasons for the sales beyond the documented acquisition and compensation nature.
TL;DR: Proper Rule 144 notice for insider sales; compliance documentation is complete for reported transactions.
The filer provides required Rule 144 details: acquisition date (06/20/2024), nature of acquisition (restricted stock vesting), planned sale date (09/24/2025), broker, and prior sales with dates and proceeds. The signature/representation language about absence of undisclosed material information is included. The filing does not include any plan adoption date under Rule 10b5-1 or additional remarks, so governance context is limited to compliance reporting rather than explanatory disclosure.